Ebola vaccines [No translation available]

Definition

Two types of Ebola vaccines have been licensed and prequalified by WHO – the live, attenuated, single-dose rVSV∆G-ZEBOV-GP vaccine (Ervebo, Merck & Co.) and the heterologous, two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen (Zabdeno and Mvabea, Janssen Pharmaceutical). Both are recommended against Ebola virus disease. They are not recommended against disease cause by other virus of the Orthoebolavirus genus. The single-dose single-dose rVSV∆G-ZEBOV-GP vaccine (Ervebo, Merck & Co.) is recommended for both outbreak response and preventive vaccination of health care and frontline workers in at-risk countries. A stockpile of vaccine doses has been established for reactive use and is management by the International Coordinating Group for vaccine provision. The two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen (Zabdeno and Mvabea, Janssen Pharmaceutica) is recommended for preventive use, outside of an outbreak response, in health care and frontline workers in at-risk countries. For more recommendation, see SAGE recommendations https://iris.who.int/bitstream/handle/10665/378109/WER9927-355-362.pdf?sequence=1&isAllowed=y [No translation available]

2 subordinate codes

• XM4P37rVSV∆G-ZEBOV-GP vaccine [No translation available]
• XM4TZ2Ad26.ZEBOV and MVA-BN-Filo vaccine [No translation available]

Also indexed as

Nearby in Unerwünschte Nebenwirkungen bei therapeutischer Anwendung: Virusimpfstoffe

• XM68M6COVID-19 vaccines [No translation available]
• XM38G7Dengue vaccines [No translation available]
• XM0RC1Encephalitis vaccines [No translation available]
• XM1LR5Influenza vaccines [No translation available]
• XM6LL6Hepatitis vaccines [No translation available]
• XM28X5Measles vaccines [No translation available]
• XM1131Mumps vaccines [No translation available]
• XM0N50Poliomyelitis-Impfstoffe